Surgical factors in bladder cancer: More (nodes) + more (pathology) = less (mortality)

BJU International

Volumn 92, Issue 3, 2003, Pages 187-

  Herr, H W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGE; BLADDER CARCINOMA; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; COMORBIDITY; CYSTECTOMY; HEALTH PROGRAM; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NOTE; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; SURGICAL RISK;

EID: 0042635476     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.04334.x     Document Type: Note

References (7)

1. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75
2. Konety BR, Joslyn SA, O'Donnell MA. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the surveillance, epidemiology and end results program data base. J Urol 2003; 169: 946-50
3. Herr HW, Bochner BH, Dalbagni G et al. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-8
4. Herr HW. Extent of surgery and pathology evaluation has an impact on bladder cancer outcomes after radical cystectomy. Urology 2003; 61: 105-8
5. Herr HW. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003; 169: 943-5
6. Bochner BH, Herr HW. Impact of separate versus en bloc pelvic lymph node dissection on the number of nodes retrieved in cystectomy specimens. J Urol 2001; 166: 2595-6
7. Herr HW. Pathologic evaluation of radical cystectomy specimens. Cancer 2002; 95: 668-9